Entity Details

Primary name LIAS_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO43766
EntryNameLIAS_HUMAN
FullNameLipoyl synthase, mitochondrial
TaxID9606
Evidenceevidence at transcript level
Length372
SequenceStatuscomplete
DateCreated2002-10-10
DateModified2021-06-02

Ontological Relatives

GenesLIAS

GO terms

Show/Hide Table
GOName
GO:0001843 neural tube closure
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0006954 inflammatory response
GO:0006979 response to oxidative stress
GO:0009107 lipoate biosynthetic process
GO:0009249 protein lipoylation
GO:0016992 lipoate synthase activity
GO:0019752 carboxylic acid metabolic process
GO:0032496 response to lipopolysaccharide
GO:0046872 metal ion binding
GO:0051539 4 iron, 4 sulfur cluster binding
GO:0102552 lipoyl synthase activity (acting on glycine-cleavage complex H protein
GO:0102553 lipoyl synthase activity (acting on pyruvate dehydrogenase E2 protein)

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion

Domains

Show/Hide Table
DomainNameCategoryType
IPR003698 Lipoyl synthaseFamilyFamily
IPR006638 Elp3/MiaB/NifBDomainDomain
IPR007197 Radical SAMDomainDomain
IPR013785 Aldolase-type TIM barrelFamilyHomologous superfamily
IPR031691 Lipoyl synthase, N-terminalDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614462 OMIMHyperglycinemia, lactic acidosis, and seizures (HGCLAS)An enzymatic defect resulting in an autosomal recessive disorder of mitochondrial metabolism. It is characterized by early-onset lactic acidosis, severe encephalomyopathy, and a pyruvate oxidation defect. Affected individuals have neonatal-onset epilepsy, poor growth, psychomotor retardation, muscular hypotonia, lactic acidosis, and elevated glycine concentration in plasma and urine. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00166 Lipoic acidDrugbanksmall molecule

Interactions

0 interactions

InteractorPartnerSourcesPublicationsLink